MYH9 and head and neck squamous cell carcinoma: As shown in Figure 4B, the OS rate of HNSCC patients with high expression levels of SLC3A2 (HR = 1.411, p = 0.012), RPN1 (HR = 1.322, p = 0.0414), NUBPL (HR = 1.365, p = 0.0229), ACTB (HR = 1.57, p = 0.00111), DSTN (HR = 1.365, p = 0.0234), FLNA (HR = 1.38, p = 0.0196), INF2 (HR = 1.366, p = 0.0232), and MYH9 (HR = 1.316, p = 0.0474) was lower.